Browse the evidence

Bariatric surgery is recommended for eligible patients with noncirrhotic MASLD to achieve sustained weight reduction and remission of type 2 diabetes.

If you have severe obesity and MASLD, discuss bariatric surgery with your doctor. It can lead to significant weight loss and remission of type 2 diabetes, reducing your risk of liver and heart disease.

A 3-month intervention combining alternate day fasting (600 kcal on fast days) and moderate-intensity aerobic exercise significantly reduces intrahepatic triglyceride content and associated cardiometabolic risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).

For patients with fatty liver disease, a 3-month program of Alternate Day Fasting (eating 600 calories on fast days, normal on others) combined with 5 weekly sessions of moderate exercise (like brisk walking or cycling) significantly reduces liver fat. This approach is a validated, mainstay therapy that works by creating a caloric deficit and improving metabolic markers, even without drastic daily calorie counting.

Intensive lifestyle interventions (dietary restriction and exercise) can induce type 2 diabetes remission, with remission rates strongly dose-dependent on the magnitude of weight loss, particularly when exceeding 15 kg.

To achieve type 2 diabetes remission, you must lose a significant amount of weight, ideally 15 kg or more, through a combination of calorie-restricted diet and regular exercise (at least 150 minutes/week). This is not just about weight loss; it requires a multidisciplinary support system including dietitians and psychological counseling to manage the mental burden of strict lifestyle changes. Shorter diabetes duration and higher BMI (27-45) predict better success.

Creatine monohydrate (3–5 g/day) increases muscle thickness and cross-sectional area in resistance training interventions lasting 8–12 weeks or more, primarily by enabling higher training volume and quality rather than direct anabolic signaling.

Take 3-5g of creatine monohydrate daily. It won't magically build muscle overnight, but it will help you lift more volume over 8-12 weeks, which leads to actual muscle growth. Don't expect results in the first few weeks.

Structured, individualized nutritional interventions significantly improve sport-specific performance and increase energy availability in competitive female athletes compared to generic guidance.

If you are a competitive female athlete, generic advice is likely not enough. You need a personalized plan that targets at least 45 kcal per kg of fat-free mass daily. Focus on consuming 5-8g of carbs and 1.6-2.0g of protein per kg of body weight. Work with a professional to adjust this gradually to avoid psychological resistance, and monitor your energy availability regularly to ensure you are not in a deficit.

Individualized nutritional interventions significantly reduce the prevalence of Female Athlete Triad risk (LEAF-Q ≥ 8) in competitive female athletes.

If you are at risk for the Female Athlete Triad, screening alone is not enough. You need a structured nutritional plan that increases your energy availability to at least 45 kcal/kg of fat-free mass daily. This involves eating enough carbohydrates and protein to support your training load, monitored by a professional to ensure you are not in a deficit.

Intermittent fasting significantly reduces body weight and BMI in overweight and obese adults compared to control diets, with alternate-day fasting showing superior weight loss effects compared to time-restricted eating.

Intermittent fasting is an effective strategy for weight loss in overweight and obese individuals. Alternate-day fasting appears to offer greater weight loss benefits than time-restricted eating. To implement, choose a method (like ADF, TRE, or 5:2) that fits your lifestyle, ensuring you maintain a caloric deficit during fasting periods. Consistency over 12+ weeks yields the best results for body composition.

Combined exercise and dietary interventions produce significantly greater body weight loss than exercise alone in adults with overweight or obesity, but do not significantly reduce ectopic fat (liver fat, visceral fat area, or intramuscular triglycerides) compared to exercise alone.

If your goal is simply to lose body weight, adding exercise to your diet will help you lose more weight than dieting alone. However, if your specific goal is to reduce ectopic fat (fat in your liver, visceral area, or muscles), simply combining diet and exercise may not be more effective than exercise alone. You may need to focus on specific types of exercise or longer durations (>12 weeks) to target these specific fat depots, as general weight loss does not guarantee ectopic fat reduction.

Long-term interventions (>12 weeks) involving either exercise or caloric restriction are successful in decreasing visceral fat area (VFA) in adults with overweight or obesity, whereas short-term interventions may not be.

To reduce visceral fat, you need to stick with your exercise or diet plan for more than 12 weeks. Short-term efforts may not be enough to target this specific type of fat. Consistency over time is key.

Progressive weight loss exceeding 30% induces 100% remission of hyperinsulinemia (HI) and insulin resistance (IR) in individuals with overweight or obesity, whereas lower weight loss thresholds yield partial or no remission.

If you have high insulin or insulin resistance, losing a small amount of weight (5-10%) will help your health, but it likely won't cure the metabolic issue. To fully reverse hyperinsulinemia and insulin resistance, you generally need to lose more than 30% of your body weight through a sustained, intensive lifestyle and medical program over a year.

Time-restricted eating (TRE) significantly reduces body weight, fat mass, BMI, and waist circumference in adults, but does not significantly reduce fat mass percentage.

If you are an adult looking to lose weight and body fat, restricting your daily eating window to 12-20 hours (fasting for 4-12 hours) is an effective strategy. You can expect significant reductions in body weight, waist circumference, and fat mass. However, be aware that this method also leads to a loss of fat-free mass (muscle) and does not significantly change your body fat percentage. It is not necessarily superior to standard calorie restriction for weight loss, but may be easier to adhere to for some people.

Reducing total caloric intake by 500-1,000 kcal daily (Low-Calorie Diet) is a safe, practical, and effective primary strategy for obesity management, yielding 0.5-1.0 kg weight loss per week.

To lose weight safely, reduce your daily calories by 500 to 1,000 compared to what you normally eat. This simple deficit typically results in losing 0.5 to 1.0 kg per week and is considered safe for most people without strict medical supervision.

Intermittent fasting (16:8 time-restricted eating) produces significantly greater weight loss and improvements in fasting glucose and triglycerides compared to standard calorie restriction in obese adults over an 8-week period.

If you are obese and struggling with weight loss, try a 16:8 intermittent fasting schedule (eat within an 8-hour window, fast for 16) for at least 8 weeks. This approach may yield better weight loss and metabolic improvements than simply counting calories, and it is generally well-tolerated.

High-intensity interval training (HIIT) elicits higher plasma lactate concentrations than work-matched moderate-intensity continuous training (MICT) during the exercise bout.

If you do HIIT, you will produce more lactate than if you did moderate continuous training of the same work. This is expected and part of what drives the unique adaptations.

Viscous fiber supplementation (median dose 8 g/day) leads to modest reductions in body weight and waist circumference in individuals on ad libitum diets, primarily through increased satiety and energy excretion.

If you are not strictly counting calories, adding about 8 grams of viscous fiber daily (found in foods like oats, beans, or supplements) can help modestly reduce body weight and waist size by making you feel fuller and slightly increasing calorie excretion.

Metabolic adaptation during weight loss involves a 15-20% reduction in daily energy expenditure beyond what is expected from mass loss, which persists until the previous weight is regained.

When you lose weight through dieting, your body burns 15-20% fewer calories than expected for your new size. This 'metabolic adaptation' does not go away over time; it stays until you regain the weight. This is why maintaining weight loss through diet alone is so difficult—you must eat significantly less than a healthy person of your new weight would.

Long-term caloric restriction (25% reduction for 24 months) induces metabolic adaptation (adaptive thermogenesis) in sleeping energy expenditure that exceeds predictions based on changes in body mass alone, with the effect persisting at 24 months when assessed using advanced MRI-derived organ and tissue mass models.

If you restrict calories by 25% for two years, your body will adapt by lowering its energy expenditure more than expected from weight loss alone. This 'metabolic adaptation' is real and persists, especially when looking at organ-level changes. To manage this, focus on preserving muscle mass through resistance training and protein intake, as the study shows lean tissue loss is part of the equation, though not the whole story of metabolic slowdown.

While fat-free mass gains are similar, 16:8 TRE results in less fat mass accumulation and lower total training volume compared to continuous feeding during a caloric surplus.

Be aware that if you switch to an 8-hour eating window, you might naturally train for less total volume and accumulate slightly less fat than if you ate all day, even in a surplus. This isn't necessarily bad—it might mean you are more efficient with your energy—but it is a trade-off to consider if your goal is maximum fat gain (bulking).

Obesity increases perioperative morbidity and technical complexity in gastrointestinal cancer surgery, including higher rates of anastomotic leak and surgical site infection.

If you are obese and undergoing gastrointestinal cancer surgery, discuss the increased risk of complications with your surgeon. Preoperative weight loss may be recommended to reduce these risks.

Following behavioral weight loss, the body enters a physiological state characterized by adaptive thermogenesis (declines in energy expenditure beyond those attributable to changes in body composition) and increased energy intake, which drive weight regain.

After losing weight, your body biologically fights to regain it by lowering your energy expenditure and increasing hunger. This is a normal physiological response, not a personal failure. To maintain weight loss, you must account for these biological changes, likely requiring ongoing behavioral support and potentially adjusted energy intake/expenditure strategies, rather than relying on the same intensity of effort used during the weight loss phase.

Using different prediction equations (Katch-McArdle vs. BIA-derived) to estimate Resting Metabolic Rate (RMR) during weight loss yields significantly different conclusions regarding the presence of metabolic adaptation (MA), with Katch-McArdle suggesting increased metabolic efficiency (increased aRMR) while BIA suggests decreased efficiency (decreased aRMR).

When tracking weight loss, do not rely on a single prediction equation to judge your metabolic health. This study shows that different formulas can contradict each other regarding metabolic adaptation. To minimize this error, prioritize preserving fat-free mass (muscle) through adequate protein intake (approx. 2.0 g/kg FFM as used in the study) and resistance training, as this stabilizes the metabolic rate more reliably than any single calculation method.

Tirzepatide treatment (5-15 mg weekly) significantly reduces serum uric acid (SUA) levels in adults with obesity or overweight, with weight reduction explaining 72.7% of this effect.

If you have obesity or overweight and are concerned about gout or high uric acid, tirzepatide (a once-weekly injection) can significantly lower your uric acid levels. Most of this benefit comes from the weight loss it causes, but it may also have direct effects. This makes it a potentially useful tool for managing gout risk in people with obesity, in addition to helping with weight loss.

Ramadan fasting significantly impairs anaerobic power (Wingate peak and mean power) and upper-body strength (bench press), but does not significantly affect lower-body maximal strength (leg press), explosive power (countermovement jump), or isometric strength (handgrip).

During prolonged fasting, expect a drop in your ability to perform high-intensity, short-duration efforts (like sprints or heavy upper-body lifts). Your leg strength and vertical jump may remain stable, but prioritize recovery and nutrition strategies for anaerobic tasks.

Exercise therapy reduces AHI and improves daytime sleepiness in OSA patients, often independently of significant weight loss, through mechanisms such as reduced leg fluid shift and improved upper airway neuromuscular control.

Incorporate 150 minutes of moderate aerobic exercise (like brisk walking) and resistance training twice a week into your routine. This can reduce the severity of your sleep apnea and improve daytime sleepiness, even if you don't lose a lot of weight. The benefits come from improved airway muscle control and reduced fluid shifts in your neck.